<DOC>
	<DOC>NCT02842086</DOC>
	<brief_summary>The primary objective of this study is to assess the rates of HIV-1 seroconversion in Men (MSM) and transgender women (TGW) who have sex with men and who are administered daily emtricitabine/tenofovir alafenamide (F/TAF) or emtricitabine/tenofovir DF (F/TDF) with a minimum follow-up of 48 weeks and at least 50% of participants have 96 weeks of follow-up.</brief_summary>
	<brief_title>Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<criteria>Key Must be at high risk of sexual acquisition of HIV HIV1 negative status MSM and TGW (male at birth) who have at least one of the following: condomless anal intercourse with at least two unique male partners in the past 12 weeks (partners must be either HIVinfected or of unknown HIV status) documented history of syphilis in the past 24 weeks documented history of rectal gonorrhea or chlamydia in the past 24 weeks Adequate renal function: estimated glomerular filtration rate ≥ 60 mL/min according to the CockcroftGault formula Adequate liver and hematologic function: Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 2.5 × upper limit of normal (ULN) and total bilirubin ≤ 1.5 mg/dL, or normal direct bilirubin Absolute neutrophil count ≥ 1000/mm^3; platelets ≥ 75,000/mm^3; hemoglobin ≥ 10 g/dL Key Exclusion Criteria Grade 3 or Grade 4 proteinuria or glycosuria that is unexplained or not clinically manageable. NOTE: Other protocol defined Inclusion/ Exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>